The largest database of trusted experimental protocols

5 protocols using hcm hepatocyte culture medium

1

Directed Differentiation of hiPSCs into Mature Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following established protocols (Cai et al., 2008 ), control, LMNA T10I, LMNA R541C hiPSCs were grown in feeder-free differentiation conditions. For efficient hepatocyte differentiation, cells were incubated in definitive endoderm media with recommended supplements (Stem Cell Technologies) for 4 days in ambient O2 and 5% CO2, yielding homogeneous monolayer of definitive endoderm cells. At day 5, cells were incubated with recombinant human BMP-4 (20ng/mL; Peprotech) and recombinant human FGF basic (10ng/mL; R&D Systems) for 5 days in RPMI-B27 (with insulin) in 5% O2 and 5% CO2, yielding hepatic progenitor cells. At day 10, cells were incubated in RPMI-B-27 (with insulin) supplemented with recombinant human HGF (20ng/mL; PeproTech) for 5 days at 5% O2 and 5% CO2, yielding immature HLCs. Finally, at d15, cells were incubated with HCM Hepatocyte Culture Medium (Lonza) without EGF and supplemented with recombinant human oncostatin M (20ng/mL; R&D Systems) for 7 days in ambient O2 and 5% CO2, yielding mature HLCs, which were collected at day 23 for subsequent ChIP, immunofluorescence, and immunoblotting.
+ Open protocol
+ Expand
2

Differentiation of hiPSCs to Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
hiPSC lines were passaged with Accutase (Innovative Cell Technologies, San Diego, CA) for 5 minutes at room temperature (RT) and plated for differentiation on Geltrex coated dishes following Stephen Duncan’s protocol with modifications.(5) For efficient DE differentiation, the DE kit (STEMCELL Technologies) was used for the first 4 days in ambient O2/5% CO2. Later, cells were cultured in RPMI‐B27 (with insulin) supplemented with BMP4 (20 ng/mL; PeproTech, Rocky Hill, NJ) and FGF2 (10 ng/mL; R&D Systems) for 5 days in 5% O2/5% CO2, followed by RPMI‐B‐27 (with insulin) supplemented with recombinant human HGF (20 ng/mL; PeproTech) for 5 days in 5% O2/5% CO2. The last stage required culturing cells in HCM Hepatocyte Culture Medium (Lonza Group AG, Basel, Switzerland) that was supplemented with recombinant human Oncostatin M (20 ng/mL; R&D Systems) for 5 days in ambient O2/5% CO2.(9)
+ Open protocol
+ Expand
3

Hepatic Differentiation Protocol from Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hepatic differentiation was performed following the protocol described in [20 (link)]. Briefly, when cells reach 70% confluency, the medium was changed for RPMI1640 media containing B27 Supplements Minus Insulin (Invitrogen), 100 ng/mL Activin A (R&D Systems), 20 ng/mL fibroblast growth factor 2 (FGF2) (R&D Systems), and 10 ng/mL bone morphogenetic protein 4 (BMP4) (PeproTech) to induce endoderm. After 8 days of culture, dishes were moved to hypoxia (4% O2) in RPMI/B27 Supplement (Invitrogen) medium with 20 ng/mL BMP4 and 10 ng/mL FGF2 for 5 days. Next, the medium was changed to RPMI/B27 supplemented with 20 ng/mL hepatocyte growth factor (HGF, PeproTech) for an additional 5 days in hypoxia. The final stage of differentiation was in HCM hepatocyte culture medium (Lonza, but omitting the EGF) supplemented with 20 ng/mL Oncostatin M (R&D Systems) for 5 days in normoxia (21% O2). During that time, the medium was freshly prepared and changed daily.
+ Open protocol
+ Expand
4

Culturing Primary Human Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved primary human hepatocytes (Lonza Biologics, United Kingdom) were cultured with HCM Thawing Medium, Hepatocyte Plating Medium and HCM Hepatocyte Culture Medium (Lonza Biologics, United Kingdom) according to supplier’s instructions. For some experiments cells were exposed to LPS from Klebsiella pneumoniae (Merck, United Kingdom) or tunicamycin (Merck, United Kingdom) according to the doses stated.
+ Open protocol
+ Expand
5

Differentiation of hiPSCs into Hepatocyte-Like Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The differentiation of hiPSCs into HLCs were performed as described previously with minor modification (Pashos et al., 2017 (link)). Briefly, we treated hiPSC at 30–40% confluence 24 hrs after plating for differentiation with Definitive Endoderm Kit from day 1 to day 4 following manufacturer’s instruction. Then, the cells were transferred into RPMI-B27 (made with 2% B-27 Supplement) supplemented with BMP-4 (20 ng/mL) and FGF basic (10 ng/mL) for 5 days in 5% oxygen/5% CO2. Subsequently, RPMI-B27 supplemented with recombinant human HGF (20 ng/mL) were applied to the cells for 5 days in 5% oxygen/5% CO2. Finally, the cells were treated with HCM Hepatocyte Culture Medium (Lonza) without EGF and hydrocortisone and supplemented with recombinant human oncostatin M (20 ng/mL) for 5 days in ambient oxygen/5% CO2, yielding mature HLCs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!